Epidemiology of multiple sclerosis in Europe: a review.
Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of the CNS with symptoms dependent on the type of the disease and the site of lesions. During the progression of the disease, symptoms become more permanent and progressive disability ensues. MS is a disease characterized by wide variations between patients, thus making categorization difficult. The aim of the current study was to review the existing epidemiological data of MS in Europe published during the last decade (2000-2009), using PubMed. Findings revealed an increasing incidence of MS during the last decade. Recent data indicate that latitude does not play a key role in determining the onset of the disease. MS has a significant impact on the quality of life for most patients over many years. The disease is twice as common in women than in men, and is at its peak in the most economically productive years of life. Pregnancy, postpartum status and vaccines may influence the onset and the course of the disease. Only one of the reviewed papers provides a view of progression from onset to death.
First Department of Neurology, AHEPA Hospital, School of Medicine, Aristotelian University, Thessaloniki 54621, Greece. efrosink@gmail.com
Ephrosyni
E
Koutsouraki
Vassiliki
V
Costa
Stavros
S
Baloyannis
D000367:Age Factors; D005060:Europe; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D009103:Multiple Sclerosis / Q000453:epidemiology* / Q000209:etiology; D049590:Postpartum Period; D011247:Pregnancy; D015995:Prevalence; D011788:Quality of Life; D012307:Risk Factors; D012737:Sex Factors; D014612:Vaccines
D014612:Vaccines